MX9708678A - Proteasa activa, soluble del virus de la hepatitis c. - Google Patents

Proteasa activa, soluble del virus de la hepatitis c.

Info

Publication number
MX9708678A
MX9708678A MX9708678A MX9708678A MX9708678A MX 9708678 A MX9708678 A MX 9708678A MX 9708678 A MX9708678 A MX 9708678A MX 9708678 A MX9708678 A MX 9708678A MX 9708678 A MX9708678 A MX 9708678A
Authority
MX
Mexico
Prior art keywords
protease
soluble
active hepatitis
virus protease
soluble hcv
Prior art date
Application number
MX9708678A
Other languages
English (en)
Other versions
MXPA97008678A (es
Inventor
Bimalendu Desmahapatra
Michael G Murray
Lata Ramanathan
Nancy J Butkiewicz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA97008678A publication Critical patent/MXPA97008678A/es
Publication of MX9708678A publication Critical patent/MX9708678A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se presenta una NS3 proteasa soluble del virus de la hepatitis C, que incluye la NS3 proteasa fusionada sobre un motivo de solubilizacion. Se presenta una fusion de las regiones NS3 y NS4 bajo condiciones en donde no están disociadas por la NS3 proteasa. Se presenta también la NS3 proteasa soluble del virus de la hepatitis C expresada de manera bacteriana. Se presentan células huéspedes donde al menos el 1% de la proteína total de la célula es NS3 proteasa soluble del virus de la hepatitis C.
MX9708678A 1995-05-12 1996-05-09 Proteasa activa, soluble del virus de la hepatitis c. MX9708678A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08440409 1995-05-12
US08/440,409 US5843752A (en) 1995-05-12 1995-05-12 Soluble active hepatitis C virus protease
PCT/US1996/006387 WO1996036702A2 (en) 1995-05-12 1996-05-09 Soluble, active hepatitis c virus protease

Publications (2)

Publication Number Publication Date
MXPA97008678A MXPA97008678A (es) 1998-02-01
MX9708678A true MX9708678A (es) 1998-02-28

Family

ID=23748650

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9708678A MX9708678A (es) 1995-05-12 1996-05-09 Proteasa activa, soluble del virus de la hepatitis c.

Country Status (7)

Country Link
US (1) US5843752A (es)
EP (1) EP0826038A2 (es)
JP (1) JP3091231B2 (es)
AU (1) AU5729196A (es)
CA (1) CA2220575C (es)
MX (1) MX9708678A (es)
WO (1) WO1996036702A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741077B1 (fr) * 1995-11-14 1998-01-23 Pasteur Institut Vaccin polyvalent anti-dengue
AU2933797A (en) * 1996-05-10 1997-12-05 Schering Corporation Synthetic inhibitors of hepatitis c virus ns3 protease
US5990276A (en) * 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
IT1285158B1 (it) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
US6436666B1 (en) 1996-10-17 2002-08-20 Chiron Corporation Protease regulator screening assay
WO1998037180A2 (en) * 1997-02-22 1998-08-27 Abbott Laboratories Hcv fusion protease and polynucleotide encoding same
US6010848A (en) * 1997-07-02 2000-01-04 Smithkline Beecham Corporation Screening methods using an atpase protein from hepatitis C virus
GB9717953D0 (en) 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
US6211338B1 (en) * 1997-11-28 2001-04-03 Schering Corporation Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
WO2000001718A2 (en) * 1998-07-02 2000-01-13 University Of Florida Ns4a-ns3 catalytic domain of hepatitis c
JP2002534084A (ja) 1999-01-08 2002-10-15 ブリストル−マイヤーズ スクイブ カンパニー Ｃ型肝炎ウイルスｎｓ３プロテアーゼの修飾形
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
US6562346B1 (en) * 1999-10-27 2003-05-13 Chiron Corporation Activation of HCV-specific T cells
US6986892B1 (en) * 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
US20050074465A1 (en) * 1999-11-24 2005-04-07 Michael Houghton HCV fusion proteins with modified NS3 domains
EP1350105B1 (en) 2000-06-15 2007-07-25 Novartis Vaccines and Diagnostics, Inc. Immunoassays for anti-hcv antibodies
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
AR029851A1 (es) * 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
PL206255B1 (pl) * 2000-07-21 2010-07-30 Dendreon Corporationdendreon Corporation Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii
BR0112666A (pt) 2000-07-21 2003-06-10 Schering Corp Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
NZ538711A (en) * 2002-09-09 2007-01-26 Chiron Corp Antigen/antibody/antigen sandwich assays for detecting hepatitis C virus infections
CA2498653C (en) * 2002-10-29 2010-12-14 Boehringer Ingelheim International Gmbh Inhibitor-resistant hcv ns3 protease
WO2004048403A2 (en) * 2002-11-26 2004-06-10 Tripep Ab Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element
US7827284B2 (en) * 2002-12-20 2010-11-02 Netsocket, Inc. Method and arrangement in a communication system
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP4836281B2 (ja) * 2004-08-27 2011-12-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド Ｈｃｖ非構造タンパク質変異体およびその使用
EP2109748B1 (de) 2007-01-18 2010-04-14 Steyr Mannlicher Holding GmbH Laufhalterung für eine kipplaufwaffe
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
US8815253B2 (en) 2007-12-07 2014-08-26 Novartis Ag Compositions for inducing immune responses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0527788B1 (en) * 1990-04-04 2004-06-30 Chiron Corporation Hepatitis c virus protease
IT1272179B (it) * 1994-02-23 1997-06-16 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
US5714371A (en) * 1995-05-12 1998-02-03 Schering Corporation Method for refolding insoluble aggregates of hepatitis C virus protease

Also Published As

Publication number Publication date
WO1996036702A3 (en) 1997-01-16
WO1996036702A2 (en) 1996-11-21
CA2220575C (en) 2001-12-25
AU5729196A (en) 1996-11-29
CA2220575A1 (en) 1996-11-21
US5843752A (en) 1998-12-01
JP3091231B2 (ja) 2000-09-25
JPH10507933A (ja) 1998-08-04
EP0826038A2 (en) 1998-03-04

Similar Documents

Publication Publication Date Title
MX9708678A (es) Proteasa activa, soluble del virus de la hepatitis c.
CA2079105A1 (en) Hepatitis c virus protease
CA2303526A1 (en) Hepatitis c virus cell culture system
WO2001002601A3 (en) Cell-based assay systems for examining hcv ns3 protease activity
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
AU2347997A (en) Synthesis and purification of hepatitis c virus-like particles
NZ319786A (en) HCV NS3 protein fragments with helicase activity and improved solubility
CA2005950A1 (en) Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
ITRM940092A0 (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
HK1038573A1 (en) Method to identify agents active against hcv by using the structure coordinates of hepatitis c virus protease
WO1999028482A3 (en) Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide
EP0732340A3 (en) Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
CA2220729A1 (en) Method for refolding insoluble aggregates of hepatitis c virus protease
YU71195A (sh) Prečišćeni proteini papilomavirusa
MX9708679A (es) Sustratos disociables, solubles de la proteasa del virus de la hepatitis c.
FR2732978B1 (fr) Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes
AU4397097A (en) Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
FI923020A0 (fi) Inte a inte b-sekvenser.
EP0288198A3 (en) Production of peptide
AU5069800A (en) Novel gbv sequence
EP0385394A3 (en) Polyhedrin gene and genetic engineering thereof
EP1424390A4 (en) INTAKE HEPATITIS-C VIRUS AND METHOD FOR ITS CULTURE IN AN IN VITRO CELL CULTURE
SI1118619T1 (en) Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees